4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone [4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinon]
topical
- Terms
-
Ro 1724
Ro 20 1724
Ro 20-1724
Ro 201724
Persistent link
https://www.medvik.cz/link/D012368
Definition
Inhibitor of phosphodiesterases.
- DUI
- D012368 MeSH Browser
- CUI
- M0019225
- CAS
- 2-Imidazolidinone, 4-((3-butoxy-4-methoxyphenyl)methyl)-
- Previous indexing
- Benzyl Compounds (1972-1974); Imidazoles (1972-1974); Ethers (1974)
- History note
- 2005(1975)
- Public note
- 2005; see RO 21 1724 1991-2004;see IMIDAZOLES 1975-1990
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.383.129.308.090
Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide
D03.383.129.308.100
4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone
D03.383.129.308.270
Fadrozole
D03.383.129.308.385
Histidinol
D03.383.129.308.445
Impromidine
D03.383.129.308.626
Niridazole